Northern Trust Corp Soligenix, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.51 - $117.79 $3,526 - $814,517	6,915 Added 13.53%	58,031 $25,000
Q1 2021 May 12, 2021	BUY	$1.31 - $2.35 $3,472 - $6,229	2,651 Added 5.47%	51,116 $78,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $2.61 $26,926 - $41,339	15,839 Added 48.55%	48,465 $87,000
Q2 2020 Aug 14, 2020	BUY	$1.36 - $2.26 $16,324 - $27,126	12,003 Added 58.2%	32,626 $69,000
Q1 2019 May 13, 2019	BUY	$0.88 - $1.04 $18,148 - $21,447	20,623 New	20,623 $19,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.